146 related articles for article (PubMed ID: 38006395)
1. High expression of integrin-binding sialoprotein (IBSP) is associated with poor prognosis of osteosarcoma.
Ma Y; Chen B; Zhang B; Zhang C; Zhu Q; Wang X; Liu Z; Liu H
Aging (Albany NY); 2023 Nov; 16(1):28-42. PubMed ID: 38006395
[TBL] [Abstract][Full Text] [Related]
2. IBSP, a potential recurrence biomarker, promotes the progression of colorectal cancer via Fyn/β-catenin signaling pathway.
Chen Y; Qin Y; Dai M; Liu L; Ni Y; Sun Q; Li L; Zhou Y; Qiu C; Jiang Y
Cancer Med; 2021 Jun; 10(12):4030-4045. PubMed ID: 33987980
[TBL] [Abstract][Full Text] [Related]
3. Pan-cancer analysis shows that IBSP is a potential prognostic and immunotherapeutic biomarker for multiple cancer types including osteosarcoma.
Pan B; Cheng X; Tan W; Liu R; Wu X; He J; Fan Q; Zhang Y; Cheng J; Deng Y
Front Immunol; 2023; 14():1188256. PubMed ID: 37457709
[TBL] [Abstract][Full Text] [Related]
4. TopBP1 promotes malignant progression and correlates with poor prognosis in osteosarcoma.
Wu DP; Yan XB; Liu LG; Tian C; Han K; Zhang H; Min DL
Eur Rev Med Pharmacol Sci; 2017 Sep; 21(18):4022-4031. PubMed ID: 29028101
[TBL] [Abstract][Full Text] [Related]
5. Prognostic significance of high NPC2 expression in gastric cancer.
Yao Y; Ren J; Lu J; Sui Y; Gong J; Chen X
Sci Rep; 2023 Nov; 13(1):20710. PubMed ID: 38001127
[TBL] [Abstract][Full Text] [Related]
6. High Expression of XRCC6 Promotes Human Osteosarcoma Cell Proliferation through the β-Catenin/Wnt Signaling Pathway and Is Associated with Poor Prognosis.
Zhu B; Cheng D; Li S; Zhou S; Yang Q
Int J Mol Sci; 2016 Jul; 17(7):. PubMed ID: 27455247
[TBL] [Abstract][Full Text] [Related]
7. SLC19A1 May Serve as a Potential Biomarker for Diagnosis and Prognosis in Osteosarcoma.
Li C; Yuan B; Yu X; Ju L; Ma Y; Guo D; Zhang K
Clin Lab; 2020 Nov; 66(11):. PubMed ID: 33180421
[TBL] [Abstract][Full Text] [Related]
8. MTHFD1L as a folate cycle enzyme correlates with prognostic outcome and its knockdown impairs cell invasive behaviors in osteosarcoma via mediating the AKT/mTOR pathway.
Wang L; Yang Y; Wang XM; Wang CQ; Zhang YM; Li BL
J Recept Signal Transduct Res; 2020 Dec; 40(6):584-590. PubMed ID: 32456526
[TBL] [Abstract][Full Text] [Related]
9. MiR-384 Inhibits Malignant Biological Behavior Such as Proliferation and Invasion of Osteosarcoma by Regulating IGFBP3.
Tan Y; Chen L; Li S; Hao H; Zhang D
Technol Cancer Res Treat; 2020; 19():1533033820909125. PubMed ID: 32129151
[TBL] [Abstract][Full Text] [Related]
10. Vitronectin significantly influences prognosis in osteosarcoma.
Shi K; Lan RL; Tao X; Wu CY; Hong HF; Lin JH
Int J Clin Exp Pathol; 2015; 8(9):11364-71. PubMed ID: 26617861
[TBL] [Abstract][Full Text] [Related]
11. High levels of long non-coding RNA DICER1-AS1 are associated with poor clinical prognosis in patients with osteosarcoma.
Hu XH; Dai J; Shang HL; Zhao ZX; Hao YD
Eur Rev Med Pharmacol Sci; 2018 Nov; 22(22):7640-7645. PubMed ID: 30536305
[TBL] [Abstract][Full Text] [Related]
12. MiR-455-3p downregulation facilitates cell proliferation and invasion and predicts poor prognosis of osteosarcoma.
Yi X; Wang Y; Xu S
J Orthop Surg Res; 2020 Oct; 15(1):454. PubMed ID: 33008443
[TBL] [Abstract][Full Text] [Related]
13. PLA2G16 Expression in Human Osteosarcoma Is Associated with Pulmonary Metastasis and Poor Prognosis.
Liang S; Ren Z; Han X; Yang J; Shan L; Li L; Wang B; Zhang Q; Mu T; Chen K; Xiong S; Wang G
PLoS One; 2015; 10(5):e0127236. PubMed ID: 25993412
[TBL] [Abstract][Full Text] [Related]
14. Circular RNA circ-NT5C2 acts as a potential novel biomarker for prognosis of osteosarcoma.
Nie WB; Zhao LM; Guo R; Wang MX; Ye FG
Eur Rev Med Pharmacol Sci; 2018 Oct; 22(19):6239-6244. PubMed ID: 30338784
[TBL] [Abstract][Full Text] [Related]
15. Serum microRNA-221 functions as a potential diagnostic and prognostic marker for patients with osteosarcoma.
Yang Z; Zhang Y; Zhang X; Zhang M; Liu H; Zhang S; Qi B; Sun X
Biomed Pharmacother; 2015 Oct; 75():153-8. PubMed ID: 26422796
[TBL] [Abstract][Full Text] [Related]
16. Elevated long noncoding RNA HAGLROS expression correlates with clinical progression and prognosis in osteosarcoma.
Wu PF; Dai ZT; Liu WD; Zhao ZX; Kong YH
Eur Rev Med Pharmacol Sci; 2019 Feb; 23(4):1428-1433. PubMed ID: 30840263
[TBL] [Abstract][Full Text] [Related]
17. Decreased expression of STAT5A predicts poor prognosis in osteosarcoma.
Guo Z; Tang Y; Fu Y; Wang J
Pathol Res Pract; 2019 Mar; 215(3):519-524. PubMed ID: 30638860
[TBL] [Abstract][Full Text] [Related]
18. Identification of abnormally high expression of POGZ as a new biomarker associated with a poor prognosis in osteosarcoma.
Zheng S; Liu Y; Sun H; Jia J; Wu T; Ding R; Cheng X
Eur J Histochem; 2021 Sep; 65(3):. PubMed ID: 34474553
[TBL] [Abstract][Full Text] [Related]
19. miR-21 predicts poor prognosis in patients with osteosarcoma.
Ren X; Shen Y; Zheng S; Liu J; Jiang X
Br J Biomed Sci; 2016 Oct; 73(4):158-162. PubMed ID: 27922432
[TBL] [Abstract][Full Text] [Related]
20. pFAK-Y397 overexpression as both a prognostic and a predictive biomarker for patients with metastatic osteosarcoma.
Thanapprapasr K; Nartthanarung A; Thanapprapasr D; Jinawath A
PLoS One; 2017; 12(8):e0182989. PubMed ID: 28846700
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]